High Alert Medications Abdulhadi Burzangi Pharm.D

Slides:



Advertisements
Similar presentations
The management of adverse drug reactions I Ralph Edwards
Advertisements

Drug Calculations CWFS F1 Programme Safe Prescribing Module
High-Alert Medications: Safeguarding Against Errors (Part 1)
ICE-PAC Kickoff Meeting. Gap Analysis A proposed approach to this gap analysis is a two phase approach – Phase I: Identify Gaps using three responses.
MEDICATION SAFETY Meeting HFAP Accreditation Standards for Pharmacy Services and Medication Use Part One.
High-Alert Medications: Safeguarding Against Errors (Part 2)
Institute for Safe Medication Practices
Introduction:  The preparation of parenteral admixture usually involves the addition of one or more drugs to large volume solutions such as intravenous.
MEDICATION SAFETY Kim Donnelly, RPh
Pharmacology Ch 4-9. Drug Controls Federal Food & Drug Act – 1906 Federal Food & Drug Act – 1906 Required identification of dangerous or addictive drugs.
Chapter 19 Critical Care IV Calculations
Presented by:Kenny-Joe Wallen Independent Double Checks for High Alert Medications in the Perioperative period.
Error Prone Abbreviations
Reporting Patient Focused Products David Cousins.
Some Important Tips for JCI Survey
Medication Safety Part 2
Buyers Taking an Active Role in Patient Safety Patrick Gallagher, CPhT Pharmacy Buyer Marian Medical Center.
By Ruth Kavita Senior Pharmaceutical Technologist, KNH.
Medication Safety.
Dr. Rosaline Kinuthia Clinical pharmacist KNH. Optimize patients outcomes through the judicious, safe, efficacious, appropriate and cost effective use.
Definition:  medication that have a higher likelihood of causing injury if they are misused. Errors with these medications are not necessarily more frequent-
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 5 Medication Errors: Preventing and Responding.
Managing Hospital Safety: Common Safety Concerns (Hospital-focused presentation) Part 3 of 4.
Introduction to Pharmacology PHARM TECH. Pharmacology  Pharmacology is the science that deals with the study of therapeutic (beneficial) agents.  Knowledge.
Medication Use Process Part One, Lecture # 5 PHCL 498 Amar Hijazi, Majed Alameel, Mona AlMehaid.
Annual Topic of Current Interest Medication Incidents Annual Topic of Current Interest Medication Incidents 2001/2002 Annual Report: Hospital Pharmacy.
Introduction to Pharmacology. Nurse Practice Act Defines scope Role of the LPN.
DVT Prevention and Anticoagulant Management
AFAMS EO Storage of ISMP High Alert Medications (Dari) 01/09/2013.
High Risk Medications Narcotics and Sedatives Alex Kardos R.Ph. Director of Pharmacy Services Robert Wood Johnson University Hospital Hamilton.
 U.S. drug legislation Sets official drug standards Defines prescription drugs Regulates controlled substances Improves safety Requires proof of efficacy.
Agents Used to Treat Seizures and Epilepsy Chapter 31.
 Medication safety terminology  Relationship between medication errors, adverse drug events & adverse drug reactions  Medication error classification.
Copyright © 2011 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 30 Medication Administration.
Emtenan AlHarbi,Mcs Clinical pharmacist
Managing Hospital Safety: Common Safety Concerns Part 1 of 4.
I n t e g r i t y - S e r v i c e - E x c e l l e n c e Air Force Pharmacy New JCAHO/Inspection Standards – P&T Implications & Critical Elements of Design.
ESRD Network 6 5 Diamond Patient Safety Program Medication Reconciliation 2009.
Copyright © 2015 Cengage Learning® Chapter 9 Parenteral Medication Labels and Dosage Calculation.
Preventing Errors in Medicine
CHSP and CalHEN Opioid Adverse Drug Event Prevention Gap Analysis: Survey Findings August 14, 2013, 2013.
Managing Hospital Safety: Common Safety Concerns Part 4 of 4.
Copyright © 2015 Cengage Learning® Chapter 9 Parenteral Medication Labels and Dosage Calculation.
Chapter 17 : Medication Errors
Launch of Supplementary Drug Charts
Math Competency Dimensional Analysis (DA) Patricia Kelliher RN, MS NUR 1020B Office B building.
Non-vitamin K antagonist oral anticoagulants (NOACs)
Safe use of HYDROmorphone
Copyright © 2013 by Saunders, an imprint of Elsevier Inc. All rights reserved. 1 Chapter 14 Medication Safety and Error Prevention.
ADVERSE DRUG EVENT (ADE) Driver Diagram OHA HEN 2.0.
Copyright © 2010 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 9 Parenteral Medication Labels and Dosage Calculation.
ANTICOAGULATION The objectives of this section are: To be able to write prescriptions according to local anticoagulation guidelines To know how to prescribe.
Chapter 31 Medication Administration. Injections: Intravenous  Three methods:  As mixtures within large volumes of IV fluids  By injection of a bolus.
Social Pharmacy and Medication Errors.
Heparin, Insulin & other meds
The “Rights” (and Wrongs) of Medication Administration
The “Rights” (and Wrongs) of Medication Administration
Medication Errors Look-Alike/Sound-Alike Medications
علیرضا تسعیری - بیمارستان قلب و عروق جوادالائمه (ع) مشهد
Medication Errors Chapter 11
Patient Safety and Quality Improvement
Medical Dosage Calculations A Dimensional Analysis Approach
Paediatric Daily Fluid Prescription & Balance Chart 2017
Medication Safety & Anticoagulation
Improving Medication Safety
BSc. Pharmacy, MSc. Clinical Pharmacy, PhD. Student
8 Medication Errors and Prevention.
Preventing Medication Errors
Presentation transcript:

High Alert Medications Abdulhadi Burzangi Pharm.D Presented by : Abdulhadi Burzangi Pharm.D

Introduction all hospital’s pharmacy still complainhng of medications errors problems which lead to increasing number of patients die until now…. The research for the methods or ways to reduce these medications errors is a great challenge… So…we must know more information about medications that consider as High Alert Medications and how to deal with them?

Key points Definition. High alert medications. The top five high-alert medications. Reduce the risks of high-alert drugs. Safeguards for the use of high alert medications.

I. Definition High Alert Medications : Drugs that bear a heightened risk of causing significant patient harm when they are used in error. Although mistakes may or may not be more common with these drugs, the consequences of an error are clearly more devastating to patients.

II. High Alert Medications Classes/Categories of Medications Adrenergic agonists I.V (e.g, epinephrine, phenylephrine, norepinephrine ). Adrenergic antagonists I.V ( e.g, propranolol, metoprolol, labetalol ) Anasthetic agents: inhaled and IV ( e.g, propofol, ketamine ) Antiarrhythmics, I.V ( e.g, lidocaine, amiodarone ). Anticoagulant : (e.g, heparin, warfarin ). Chemotherapeutic agents : parentral and oral. Oral hypogylcemics. Inotropic medications I.V ( e.g, digoxin , milrinone ). Moderate sedation agents I.V (e.g, midazolam), Oral (e.g, chloral hydrate) Narcotics/Opiates I.V, transdermal and oral. Neuromuscular blocking agents ( e.g, succinylcholine).

Cont.. Specific medications Colchicine injection . Insulin : S.C and I.V. Magnesium sulfate injection. Methotrexate : oral ( non – oncologic use ) . Oxyticin I.V. Nitroprusside sodium for injection. Potassium chloride for injection . Promethazine I.V. Sodium chloride for injection.

III. The top five high-alert medications 1- Insulin. 2- Opiate and Narcotics. 3- Injectable Potassium chloride or phosphate. 4- Injectable Anticoagulant. 5- Sodium chloride solution above 0.9%.

1- Insulin III. The top five high-alert medications Hypoglycemia is the most common complication of any insulin therapy. Factors contributing to harm : - Complexity of dosing. - Frequent monitoring. - Pharmacokinetics differ based on insulin type.

Cont.. - Many insulin products available : ( look alike – sound alike names ) - Lack of dose check systems - Insulin and heparin vials kept in close proximity to each other on a nursing unit, leading to mix-ups. - Use of "U" as an abbreviation for "units" in orders (which can be confused with "O," resulting in a 10-fold overdose) - Incorrect rates being programmed into an infusion pump.

2- Opiates and Narcotics Cont.. 2- Opiates and Narcotics Factors contributing to harm : • Calculation errors. • IV to PO conversion errors. • Errors converting potency when changing from one narcotic to another. • Many dosage forms.

Cont.. Adverse effet : - Respiratory depression - Confusion - Lethargy - Parenteral narcotics stored in nursing areas as floor stock. - Confusion between hydromorphone and morphine. - Patient-controlled analgesia (PCA) errors regarding concentration and rate. Adverse effet : - Respiratory depression - Confusion - Lethargy

Cont.. 3- Injectable Potassium Chloride or Phosphate Common Risk Factors - Storing concentrated potassium chloride/phosphate outside of the pharmacy. - Requests for unusual concentrations.

Cont.. Adverse effect : 1- Muscular or respiratory paralysis. 2- Mental confusion. 3- Hypotension. 4- Cardiac arrhythmia. 5- Heart block.

4- Injectable anticoagulant ( Heparin ) Common Risk Factors Cont.. 4- Injectable anticoagulant ( Heparin ) Common Risk Factors • Narrow therapeutic range. • Complex dosing. • Frequent monitoring. • Patient compliance. • Many interaction : – Other prescription medication. – OTC medications. – Herbal products. – Food.

Cont.. - Unclear labeling regarding concentration and total Common Risk Factors - Unclear labeling regarding concentration and total volume. - Multi-dose containers. - Confusion between heparin and insulin due to similar measurement units.

5- Sodium chloride solution above 0.9% Cont.. 5- Sodium chloride solution above 0.9% Common Risk Factors - Storing sodium chloride solutions (above 0.9%) on nursing units. - Large number of concentrations/formulations available. - No double check system in place.

IV. Reduce the risks of high-alert drugs Three formulas: 1. Standardize error-prevention processes. 2. Make errors apparent. 3. Minimize the consequences of errors that reach the patient.

Standardize error-prevention processes Cont.. Standardize error-prevention processes Technological aids: 1- Computerized prescriber order entry (CPOE) 2- Bar coding Make patient information readily accessible:

a. Perform independent double checks Cont.. 2. Make errors apparent a. Perform independent double checks b. Rely on redundancies. c. Listen for bells and whistles.

a. Perform independent double checks Cont.. a. Perform independent double checks Have another person verify the medication order and infusion pump setting : just before you start an infusion. every time you change an infusion rate. every time you replace an empty infusion bag or cassette. Use this method exclusively for high-alert drugs to avoid double-check fatigue and complacency.

Cont.. b. Rely on redundancies Match high-alert drug orders to the patient’s diagnosis, the drug’s indication, and vital patient information. If possible, avoid verbal orders. If they’re necessary, write down the order in the chart and then read back: patient name drug order as written spelling of the drug name

3. Minimize consequences of errors Cont.. 3. Minimize consequences of errors A. Closely monitoring the patient’s - level of consciousness - vital signs - respiratory status - lab results B. Ensuring that reversal agents and resuscitation equipment are readily available

V. Safeguards for the use of high alert medications - Removal high concentrate electrolytes (e.g. potassium chloride, potassium phosphate and sodium chloride) from all nursing units. Stop using dangerous abbreviations such as “u”. Use of a leading zero before a decimal place. - Review the hospital formulary for sound-alike and look-alike medications.

Cont.. Use of “tall man” letters for sound-alike and look-alike names (e.g. DOBUTamine and DOPamine). Careful review of how products are arranged on shelves to avoid similar packaged or sound-alike medications being side by side. Use flow-control pumps for continuous intravenous (I.V.) infusions. - Educate patients and family and encourage their participation in care.

Conclusion - Use of visible coloured auxiliary warning labels. I wish to apply this procedure in this hospital.

References 5 Million Lives Campaign Getting Started Kit: Prevent Harm from High-Alert Medications How-to Guide. Institute for Healthcare Improvement, 2007. http://www.ismp.org/newsletters/acutecare/articles/20070517.asp

THANK YOU